Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report) and Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk.
Volatility & Risk
Day One Biopharmaceuticals has a beta of -1.46, meaning that its share price is 246% less volatile than the S&P 500. Comparatively, Nature’s Sunshine Products has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent ratings and price targets for Day One Biopharmaceuticals and Nature’s Sunshine Products, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Day One Biopharmaceuticals | 0 | 1 | 7 | 1 | 3.00 |
| Nature’s Sunshine Products | 0 | 0 | 3 | 0 | 3.00 |
Valuation & Earnings
This table compares Day One Biopharmaceuticals and Nature’s Sunshine Products”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Day One Biopharmaceuticals | N/A | N/A | -$188.92 million | ($1.03) | -11.85 |
| Nature’s Sunshine Products | $445.32 million | 0.60 | $15.08 million | $0.88 | 16.41 |
Nature’s Sunshine Products has higher revenue and earnings than Day One Biopharmaceuticals. Day One Biopharmaceuticals is trading at a lower price-to-earnings ratio than Nature’s Sunshine Products, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Day One Biopharmaceuticals and Nature’s Sunshine Products’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Day One Biopharmaceuticals | N/A | -22.40% | -19.79% |
| Nature’s Sunshine Products | 3.81% | 11.08% | 7.23% |
Insider & Institutional Ownership
88.0% of Day One Biopharmaceuticals shares are owned by institutional investors. Comparatively, 79.4% of Nature’s Sunshine Products shares are owned by institutional investors. 8.4% of Day One Biopharmaceuticals shares are owned by insiders. Comparatively, 4.7% of Nature’s Sunshine Products shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
Nature’s Sunshine Products beats Day One Biopharmaceuticals on 8 of the 13 factors compared between the two stocks.
About Day One Biopharmaceuticals
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
About Nature’s Sunshine Products
Nature’s Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature’s Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature’s Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
Receive News & Ratings for Day One Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Day One Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
